| Ytd | 68.56% | |
| 1y | 137.87% |
| Open | Prev Close | 72.55 | Low | High | Mkt Cap | 8.78B | |||
| Vol | 0.00 | Avg Vol | 1.56M | EPS | 0.21 | P/E | 345.48 | Forward P/E | 43.48 |
| Beta | N/A | Short Ratio | 3.92 | Inst. Own | 91.74% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 82.11 | 200-d Avg | 58.17 | 1yr Est | 106.94 |
STRL, INOD and LGN are benefiting from AI-driven engineering demand as infrastructure spending and s
Guggenheim analyst Joseph Osha maintains Legence (NASDAQ:LGN) with a Buy and raises the price tar
Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and raises the pr
Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the
Barclays analyst Adam Seiden maintains Legence (NASDAQ:LGN) with a Equal-Weight and raises the pr
BMO Capital analyst Devin Dodge maintains Legence (NASDAQ:LGN) with a Outperform and raises the p
BTIG analyst Gregory Lewis maintains Legence (NASDAQ:LGN) with a Buy and raises the price target
Legence (NASDAQ: LGN) shares reversed Thursday, turning lower despite Q1 revenue beat, above-estimat
Legence (NASDAQ:LGN) raises FY2026 sales outlook from $3.700 billion-$3.900 billion to $4.100 billio
Legence (NASDAQ:LGN) reported quarterly earnings of $0.13 per share which missed the analyst consens
CNN Business Fear & Greed Index measures market sentiment with a range of 0-100. Its reading of
U.S. stock futures up, Dillard's, Cisco, Applied Materials, Doximity, Legence expected to report
Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform rating
Loop Capital analyst Jeffrey Stevenson initiates coverage on Legence (NASDAQ:LGN) with a Buy rati
GLJ Research analyst Austin Wang initiates coverage on Legence (NASDAQ:LGN) with a Buy rating and
Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price t
Top analysts changed ratings for OVV, ALMS, CLMT, LGN, RCKT, UTHR, VNT, HOOD. See full changes at be